Annie Killoran, MD, MSc
Introduction
Dr. Annie Killoran, MD is a Clinical Associate Professor of Neurology and adjunct Clinical Associate Professor of Psychiatry at the University of Iowa Carver College of Medicine. A specialist in movement disorders, she brings a rich background in clinical care, research, and education. Dr. Killoran completed her medical degree at University College Dublin and pursued a fellowship in Experimental Therapeutics in Movement Disorders at the University of Rochester. She previously served as Director of the Movement Disorders Clinic at West Virginia University and currently directs the Movement Disorder Fellowship at Iowa. Dr. Killoran is also the founder of the UIHC Neuropalliative Care Clinic and a recognized leader in Huntington’s and Parkinson’s disease research, with numerous peer-reviewed publications and active roles in national and international clinical trials.
Current Positions
- Clinical Associate Professor of Neurology
- Clinical Associate Professor of Psychiatry
Education
- MS in Pathology and Molecular Medicine, Queen’s University, Kingston, Canada
- MD in Medicine, University College Dublin, National University of Ireland, Dublin, Ireland
- Resident in Neurology, Michigan State University, East Lansing, Michigan, United States
- Fellow in Movement Disorders - Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, United States
Licenses & Certifications
- Medical License, Iowa Medical Board, Iowa
- Board Certification, American Board of Psychiatry and Neurology (adult neurology)
Selected Publications
- Nopoulos S, Reasoner EE, Ogilvie AC, Killoran A, Schultz JL. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis. Parkinsonism and Related Disorders. 2024 Feb;119:105954.
- Considine CM, Eddy CM, Frank SA, Kostyk SK, Oosterloo M, Killoran A, Furr Stimming E, Dose M, Cruickshank T, Bird TD, Vetter L, Arnesen A, Valvano J, Lange HW, Claassen DO. Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease: Considering Nonmotor Presentations. Neurol Clin Pract. 2025 Apr;15(2):e200427.
- Cook L, Verbrugge J, Schwantes-An TH, Schulze J, Foroud T, Hall A, Marder KS, Mata IF, Mencacci NE, Nance MA, Schwarzschild MA, Simuni T, Bressman S, Wills AM, Fernandez HH, Litvan I, Lyons KE, Shill HA, Singer C, Tropea TF, Vanegas Arroyave N, Carbonell J, Cruz Vicioso R, Katus L, Quinn JF, Hodges PD, Meng Y, Strom SP, Blauwendraat C, Lohmann K, Casaceli C, Rao SC, Ghosh Galvelis K, Naito A, Beck JC, Alcalay RN. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study. Brain. 2024 Aug 1;147(8):2668-2679. (As a Parkinson Study Group PD GENEration investigator).
- Tezenas du Montcel S, Petit E, Olubajo T, Faber J, Lallemant-Dudek P, Bushara K, Perlman S, Subramony SH, Morgan D, Jackman B, Paulson HL, Öz G, Klockgether T, Durr A, Ashizawa T; READISCA Consortium Collaborators. Baseline Clinical and Blood Biomarkers in Patients with Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3. Neurology. 2023 Apr 25;100(17):e1836-e1848. (as a READISCA Consortium Collaborator)
- Killoran, A. Biomarkers in Huntington Disease. In Neurodegenerative Diseases Biomarkers. PV Peplow, B Martinez and TA Gennarelli (eds.) Neuromethods, vol 173. 10/2021
- Schultz JL, Nopoulos PC, Killoran A, Kamholz JA. Statin Use and Delayed Onset of Huntington Disease. Movement Disorders. 2019;34(2):281-285
- Schultz, J. L., Kamholz, J. A., Napoulos, P. C. & Killoran, A. Comparing risperidone and olanzapine to tetrabenazine for the management of chorea in Huntington Disease. Movement Disorders Clinical Practice.
- Schultz, J. L., Nopoulos, P. C., Killoran, A. & Kahmolz, J. A. (2018). Statin Use and Delayed Onset of Huntington Disease. Movement Disorders.
- Mendez, A. A., Bosco, A., Abdel-Wahed, L., Palmer, K., Jones, K. A. & Killoran, A. (2018). A Fatal Case of HSV Encephalitis with Two False-Negative PCRs. Case Reports in Neurology. Case Rep Neurol.
- Schultz, J. L., Killoran, A., Napoulos, P. C., Chabal, C. C., Moser, D. J. & Kamholz, J. A. (2018). Evaluating Depression and Suicidality in Tetrabenazine Users with Huntington Disease. Enroll-HD Congress.